maraviroc

n.

辉瑞公司生产的一种新的抗艾药；

Maraviroc
Maraviroc.
Maraviroc
Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.
Reviews of anti-infective agents: maraviroc: the first of a new class of antiretroviral agents.
Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex.
Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers
Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.
Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-...
Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with ...
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-...
Deep Sequencing to Infer HIV-1 Co-Receptor Usage: Application to Three Clinical Trials of Maraviroc in Treatment-Experienced Patients